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Abstract 
Delusional parasitosis, also known as delusional infestation or Ekbom syndrome, is a somatic type of delusional 
disorder, usually mono ‑symptomatic, in which patients are convinced they are being infested with animal parasites 
while no objective evidence to support their belief exists. Complaints are usually about skin infestation, but involvement 
of the gastrointestinal tract has also been described. We describe a case of a 59 ‑year ‑old woman with delusional 
parasitosis claiming to be infected with Strongyloides stercoralis. 
Resumo
A parasitose delirante, também conhecida como delírio de infestação ou síndrome de Ekbom, é um tipo de delírio 
somático, normalmente monossintomático, no qual os doentes estão convictos de estarem infestados por parasitas, não 
existindo, no entanto, qualquer evidência que suporte esta crença. Normalmente, a “infestação” refere ‑se à pele, mas 
“infestações” do trato gastrointestinal encontram ‑se também descritas na literatura. Relatamos um caso de uma senhora 
de 59 anos de idade com um delírio de infestação por Strongyloides stercoralis.
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INTRODUCTION
Delusional infestation was first described in 1937 as “pre‑
‑senile delusion of infestation” by Dr. Karl ‑Axel Ekbom, 
a Swedish neurologist.1 Delusional parasitosis (DP) is 
a somatic type of delusional disorder, usually mono‑
‑symptomatic, in which the patient is convinced of being 
infested with animal parasites (usually insects or worms), 
and rarely viruses and bacteria, while no objective evi‑
dence to support their belief exists.2,3 The disorder is most 
frequently seen in middle ‑aged, often socially isolated, 
women (average age is 57 ± 14 years).3 ‑6. In 1988, it was 
reported that DP was diagnosed in about seven out of 10 
000 psychiatric admissions. However, the incidence of this 
disorder is probably much higher because most cases of 
DP are treated by dermatologists and the prevalence of the 
disease reported by psychiatrists only reflects a minority 
of this population.2 Patients may describe tactile, visual 
or auditory hallucinations related to the infestation. The 
“matchbox sign” is the classic presentation, i.e. a box or 
container where various materials that have been collected 
by the patient as evidence of infestation, including any‑
thing from dust/dirt, plant or animal fibers, scabs and skin 
debris, to photographs of old/previous lesions or parasites 
are gathered.7,8 The most frequent imaginary sources of 
infestation are other people (50%), particularly those re‑
turning from a trip to developing countries but also pets 
and real infestations with parasites which were controlled 
successfully in the past.2 One possible reason for the de‑
lusional symptoms is the false interpretation of an itching 
sensation, which is a common symptom. Depending on the 
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location of the infection, excoriation erosions and cuts are 
frequent forms of self ‑harm caused by attempts to elimi‑
nate the parasites. Skin damage can be caused by obses‑
sive cleansing and the application of aggressive chemical 
or caustic substances to remove the fictitious parasite.4,6
Folie à deux, also known as shared psychotic disorder9 or 
induced delusional disorder,10 a condition in which psy‑
chiatric symptoms (delusions or hallucinations) are trans‑
ferred from one individual to another, is not uncommon in 
this disease.8
Past or comorbid psychiatric conditions are reported in 
roughly 80% of patients with DP. The most common of 
which is depression (74%), followed by substance abuse 
(24%) and anxiety (20%).8
Delusional parasitosis can be categorized into primary, 
secondary and organic forms. In primary delusional para‑
sitosis, the patient has the delusion of being infested with 
parasites, but no other psychiatric or organic disorder is 
present. The secondary and organic forms occur secondar‑
ily to other disorders, namely psychiatric and organic dis‑
ease, respectively. There are several mental disorders that 
can be associated with Ekbom syndrome, such as schizo‑
phrenia, schizophrenia spectrum disorders, depression, de‑
mentia, affective psychosis, substance–induced psychosis 
and psychosis caused by a general medical condition (eg., 
iron deficiency, anaemia). Anxiety disorders and somato‑
form disorders should be carefully distinguished from 
delusional states and may be comorbid with delusional 
disorder. DP must also be differentiated from obsessive‑
‑compulsive disorder or, according to DSM ‑5, “skin pick‑
ing disorder”, which can result in ritualized skin cleaning 
and consecutive skin lesions but without the unshakeable 
belief of it being infested by living creatures.2
The organic type of DP is linked with thyroid disease, 
anaemia, vitamin B12 deficiency, hepatitis, diabetes, in‑
fections (e.g., HIV, syphilis), cocaine abuse1,4,6 and neuro‑
logical diseases such as multiple sclerosis.11 
A thorough evaluation is required to establish the diagno‑
sis, including a complete history and physical examination. 
It is important to rule out genuine parasitosis. Formication 
and pruritus caused by medications such as amphetamines, 
cocaine, opioids, dopamine agonists, topiramate or alpha‑
‑adrenergic agents must also be considered. A review of 
current medications is essential.1 Pruritus related to sys‑
temic diseases including hyperthyroidism, renal or liver 
disease may present as a generalized itch or a crawling 
sensation in the skin. Exposure to fiberglass may produce 
itching of unknown etiology and fiberglass ‑contaminated 
clothing placed in the laundry can result in itching in an 
entire family.8
There is a case report describing a delusional parasitosis 
as presenting symptom of occipital lobe cerebrovascular 
accident.12 
A complete blood cell count, metabolic panel, thyroid‑
‑stimulating hormone and obtaining a biopsy specimen 
of lesional and perilesional skin for direct immunoflu‑
orescence may help to rule out organic disease and help 
establish an effective physician ‑patient relationship.8 If 
substance induced psychosis is suspected, a urine drug 
screen is highly valuable as well as a search of controlled 
substances that are being prescribed via a database net‑
work search. 
Brain computerized tomography (CT) is also important 
– the emergency physician should consider a psychiatric 
cause of delusions as a diagnosis of exclusion, made only 
after medical causes have been ruled out.12
DP patients often refuse psychiatric referral, as they do not 
believe that they have a psychiatric problem. In a study 
conducted in Argentina, psychiatric referral was possible 
for only 1 in 12 patients (8%). When offered, patients be‑
came upset and angry, accusing the physicians of incom‑
petence. Although aggressive reactions are rare, an attempt 
to murder a family doctor has been reported.2
Antipsychotic drugs are the most effective agents to treat 
DP. In the past, pimozide was used as the first ‑line agent, 
but it has a less favourable side effect profile compared 
with second generation (atypical) antipsychotic agents, 
and electrocardiograms are recommended to measure Q ‑T 
interval before treatment.8 While pimozide is still used suc‑
cessfully to treat DP, newer atypical antipsychotic agents 
such as risperidone, olanzapine, quetiapine and paliperi‑
done are good options because of their favourable side 
effect profiles.3,8 Risperidone is the treatment of choice for 
delusional infestation, with a recommended dose range of 
0.5 ‑2 mg daily. Low dose olanzapine (2.5 ‑12 mg daily) has 
also been shown to be effective in DP. Third ‑generation 
antipsychotics, such as aripiprazole, are likely effective 
but have not yet been studied in delusional infestation.1 
Due to the paucity of well controlled medication treatment 
studies, response rates for antipsychotic treatment has not 
been well ‑established and reported response rates vary.2 
Longer duration of untreated psychosis in patients with 
delusional infestation, like in other psychiatric diseases, 
is associated with significantly less favourable clinical 
outcomes.13 
CASE REPORT
a. History of Present Illness
A Woman of 59 ‑year ‑old, divorced, with the 6th grade of 
education. She worked as a nursing assistant in a nursing 
home. 
Presented to the Emergency Department of a central gener‑
al hospital in August of 2018, where she was first observed 
by Internal Medicine. Her complaints were swelling and 
pain in the upper limbs. Upon physical examination, no 
evidence of oedema or skin alterations was found. The 
patient claimed the symptoms were caused by a parasite 
and that she had been infected for a long period of time. A 
complete blood panel and urine drug test was unremarka‑
ble. She had a CT head scan the previous year, after com‑
plaining to her general practitioner of persistent head and 
earaches, showing no abnormalities. She had also a normal 
electrocardiogram performed two months prior. 
The patient was then referred to the psychiatric team for 
assessment. She accepted the referral, albeit with some ret‑
icence. She reported to the psychiatrist that she had been 
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infected by the parasite Strongyloides Stercolaris, describ‑
ing its life cycle in great detail. It had supposedly happened 
15 years before, when she had been living in France with 
several other people, amongst them a woman of African 
descent. She claimed this woman had “thrown the larva” 
at her, which then it lodged under her skin. After this, she 
said she had never been able to get rid of it. She had in‑
sisted multiple times with her general practitioner (GP) to 
be referred to a tropical medicine specialist, because she 
considered that general practitioners and internal medicine 
specialists were not able to handle such infections.
She claimed to have been able to catch the larva once, 
which made a “crutch” ‑like sound. The patient said she 
could feel the larvae under her skin, and that “they are 
more active at the end of the day”. 
The patient was convinced the larvae were inside her and 
that she sometimes saw them on her skin but was unable 
to catch them. She explained that, in the past, larvae had 
been expelled through the ocular mucous membrane. In 
an attempt to rid herself of the infestation, she had bought 
albendazole, without a medical prescription, and taken it 
for 4 straight months, once daily, claiming that her gastric 
upset had improved, but that “the larva was still in the 
intestine”. 
She denied taking any other substances or using any other 
methods, such as sharp objects, to get rid of the parasite. 
The patient denied restricting social contact and claimed to 
remain functional at work. She did not believe she could 
pass the parasite onto others.
b. Previous Psychiatric History
Reviewing the patient’s medical records, it was found that 
she had previous psychiatry follow ‑up, despite denying so. 
Her psychiatrist described an infestation delusion and pos‑
sible hallucinatory activity in the form of formication, as 
well as delusional interpretations. As far as it was possible 
to establish, the symptoms had been present since 2004.
In March of 2009, her mental condition worsened, show‑
ing severe anxious and depressive symptoms congruent 
with the delusional system. She was then voluntarily ad‑
mitted to a psychiatric hospital. Nevertheless, she denied 
having any kind of psychiatric disorder, claiming that the 
admission was only meant to draw blood samples. 
The patient underwent viral tests and an urine test for il‑
licit drugs as well as a formal cognitive assessment, which 
revealed no changes. 
As an inpatient, she was started on risperidone up to 6 mg/
daily, with reasonable tolerability but with poor response. 
She was then started on olanzapine up to 10 mg/daily, with 
better response and good tolerability. Upon discharge, 
follow ‑up outpatient appointments were scheduled. She 
stopped complying with the follow ‑up and psychopharma‑
cological treatment after the first appointments. She has not 
accepted referral to a Psychiatric consult by her GP since.
c. Mental Status Examination 
Mental status examination showed adequate self ‑care, the pa‑
tient was awake and oriented in all domains, with no apparent 
amnesic deficits. Her posture was hostile, and she exhibited 
an irritated mood. Speech was organized, her tone of voice in 
crescendo, quickened, and centred in the complaints related 
to the “infection”, which she described in great detail. She 
constantly called the Psychiatrist’s competence into question. 
Psychotic symptoms were present, namely delusional ideas 
of endo ‑ and ectoparasitic infestation and delusional interpre‑
tations of ordinary bodily sensations and excretions, as well 
as haptic hallucinations (in the form of formication). Visual 
and auditory illusions were most likely present in the past, but 
not upon the current evaluation. No intention of self ‑harm or 
harm to others was perceived. Sleep and appetite were main‑
tained. She displayed no insight towards her condition or to 
the necessity for treatment.
d. Follow ‑up
Upon our observation, we spoke with the patient in an at‑
tempt to validate the complaints of discomfort but alerting 
to the harmful use of daily albendazole. The patient’s will‑
ingness to initiate psychopharmacological treatment was 
also questioned, without imposing on her wishes. The pa‑
tient was discharged with indication to suspend treatment 
with albendazole, and she refused referral for psychiatric 
consult.
From what we were able to gather, the patient did not com‑
ply with the proposed treatment. She continued having 
quarrelling interactions with her GP and with doctors in 
other primary care centres, demanding further diagnostic 
exams and antibiotic treatment. She has not since been 
referred to Psychiatric evaluation.
DISCUSSION
The present case illustrates a patient with Ekbom syn‑
drome, who closely resembles the typical characteristics 
described in the literature, namely female gender, between 
the fifth and sixth decades of age, single, divorced or wid‑
owed and a low level of education. 
The patient presents with DP, arising spontaneously as a 
mono ‑delusional disorder, meeting the criteria of the In‑
ternational Classification of Diseases, 10th revision (ICD‑
‑10)10 for persistent delusional disorder and the criteria of 
the Diagnostic and Statistical Manual of Mental Disorders 
(DSM ‑5)14 for delusional disorder, somatic type. 
Reassurance regarding the lack of evidence of organic dis‑
ease rarely provides relief, and patients often see multiple 
physicians in search of someone who will believe them.8
Symptoms of DP are very real and distressing to the pa‑
tient, who often seek medical help and advice from GPs, 
dermatologists and parasitologists.2
In the diagnosis and follow ‑up of these patients, it is im‑
portant to have effective communication between different 
specialists, such as general practitioners, dermatologists 
and psychiatrists.
The most challenging and intricate problem for practition‑
ers is to sufficiently build patients’ trust and alliance, to be 
able to engage them in psychopharmacological treatment.2
The emergence of such cases in a psychiatric emergency 
setting, and regular clinical discussion meetings between 
psychiatry specialists and primary health care doctors, can 
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alert both GPs and psychiatrists to this disease, which has 
a large impact on patient’s quality of life. Many are never 
observed by a psychiatrist, which makes awareness among 
colleagues of other specialties even more relevant.
Treatment is only possible within a solid doctor ‑patient 
relationship, based on trust. This should be worked on pri‑
or to offering psychopharmacological treatment. The pri‑
mary challenge for psychiatrists and GPs is to not “lose” 
the patient to follow ‑up. Poor adherence is the main factor 
leading to ineffective treatment.7
Considering the long duration of untreated psychosis, the 
history of reiterated non ‑compliance with treatment and 
follow ‑up and the complete absence of insight, the report‑
ed case seems to have a poor prognosis. 
In conclusion, more information would be ideal, possibly 
with a close relative, to clearly define the intricacies of this 
patient’s psychiatric history, social stressors, and possible 
iatrogenic contributions to the psychosis she experienced. 
This was not manageable in the Emergency Department 
setting.
Most of the literature on this subject is limited to case 
reports and open studies. Further research including sig‑
nificant controlled and randomized studies should focus 
on thoroughly evaluating the current recommendations 
for the treatment of delusional parasitosis, due to its major 
impact on the patient’s quality of life.
Responsabilidades Éticas
Conflitos de Interesse: Os autores declaram a inexistência de conflitos de interesse na realização do presente trabalho.
Fontes de Financiamento: Não existiram fontes externas de financiamento para a realização deste artigo.
Confidencialidade dos dados: Os autores declaram ter seguido os protocolos da sua instituição acerca da publicação dos 
dados de doentes. 
Consentimento: Consentimento do doente para publicação obtido.
Proveniência e Revisão por Pares: Não comissionado; revisão externa por pares.
Ethical Disclosures 
Conflicts of Interest: The authors have no conflicts of interest to declare.
Financing Support: This work has not received any contribution, grant or scholarship.
Confidentiality of Data: The authors declare that they have followed the protocols of their work center on the publication 
of data from patients.
Patient Consent: Consent for publication was obtained. 
Provenance and Peer Review: Not commissioned; externally peer reviewed.
References
1. Moriarty N, Alam M, Kalus A, O’Connor K. Current under‑
standing and approach to delusional infestation. Am J Med. 
2019; 132: 1401 ‑9.
2. Mumcuoglu KY, Leibovici V, Reuveni I, Bonne O. Delu‑
sional parasitosis: diagnosis and treatment. Isr Med Assoc 
J. 2018;20:456 ‑60.
3. Tabbalat RR, Cal NV, Mayigegowda KK, Desilets DJ. Two 
Cases of Gastrointestinal Delusional Parasitosis Presenting 
as Folie a Deux. ACG Case Rep J. 2019 23;6:e00183. doi: 
10.14309/crj.0000000000000183.
4. Alves CJ, Martelli AC, Fogagnolo L, Nassif PW. Secondary 
Ekbom syndrome to organic disorder: report of three cases. 
An Bras Dermatol. 2010; 85: 541 ‑4.
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